Quantcast
Last updated on April 18, 2014 at 17:20 EDT

International Isotopes Inc. Announces a Notice of Allowance for its Patent Application for a New Fluorine Extraction Process

July 7, 2010

IDAHO FALLS, Idaho, July 7 /PRNewswire-FirstCall/ — International Isotopes Inc. (OTC Bulletin Board: INIS) announces it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application directed to a new fluorine extraction process (FEP). This patent application is the result of process development work completed by the Company in its Idaho pilot scale facility.

Once the patent application issues as a U.S. Patent, it will provide the Company with additional protections on the claimed fluorine extraction process. The issued U.S. patent is expected to expire May 8, 2029. The Company also plans to pursue corresponding international patent applications directed to the new process.

Steve T. Laflin, President and CEO of International Isotopes Inc. said, “The development work carried out in the Idaho pilot scale facility over the past several years has been instrumental in enhancing the efficiencies in the process and achieving the operational performance consistency necessary to scale this into a larger commercial operation. We are quite pleased with the successful work at the Idaho demonstration facility and will continue to carry out further development work there in parallel with our design and testing of certain components planned for the uranium de-conversion and fluorine extraction processing facility in Hobbs, New Mexico.”

About International Isotopes Inc.

International Isotopes Inc. manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients

International Isotopes Inc. Safe Harbor Statement

Certain statements in this press release are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements with respect to the issuance of patents, international patent protection of the FEP, development work in the Idaho pilot scale facility, anticipated commercial practicality of FEP operations, and the Company plans to build the uranium de-conversion and fluorine extraction processing facility. Information contained in such forward-looking statements is based on current expectations and is subject to change. These statements involve a number of risks, uncertainties and other factors that could cause actual results, performance or achievements of International Isotopes, Inc. to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. Other factors, which could materially affect such forward-looking statements, can be found in International Isotopes, Inc.’s filings with the Securities and Exchange Commission at www.sec.gov, including our annual report on Form 10-K for the year ending December 31, 2009. Investors, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and International Isotopes, Inc. undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


    FOR MORE INFORMATION CONTACT:

    Jim Drewitz
    Creative Options Communications
    Investor and Public Relations
    jim@jdcreativeoptions.com
    Phone:  830-669-2466

For more information, please visit the Company web site: www.intisoid.com

SOURCE International Isotopes Inc.


Source: newswire